Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study

Carolina B Ribeiro, Fernanda M Ramos, John A Manthey, Thais B Cesar, Carolina B Ribeiro, Fernanda M Ramos, John A Manthey, Thais B Cesar

Abstract

This study evaluated the potential effectiveness of different doses of Eriomin® on hyperglycemia and insulin resistance associated with other metabolic biomarkers in prediabetic individuals. Prediabetes patients (n = 103, 49 ± 10 years) were randomly divided into four parallel groups: (a) Placebo; (b) Eriomin 200 mg; (c) Eriomin 400 mg; and (d) Eriomin 800 mg. Assessment of biochemical, metabolic, inflammatory, hepatic, renal, anthropometric markers, blood pressure, and dietary parameters were performed during 12 weeks of intervention. Treatment with all doses of Eriomin (200, 400, and 800 mg) had similar effects and altered significantly the following variables: blood glucose (-5%), insulin resistance (-7%), glucose intolerance (-7%), glycated hemoglobin (-2%), glucagon (-6.5%), C-peptide (-5%), hsCRP (-12%), interleukin-6 (-13%), TNFα (-11%), lipid peroxidation (-17%), systolic blood pressure (-8%), GLP-1 (+15%), adiponectin (+19%), and antioxidant capacity (+6%). Eriomin or placebo did not influence the anthropometric and dietary variables. Short-term intervention with Eriomin, at doses of 200, 400, or 800 mg/day, benefited glycemic control, reduced systemic inflammation and oxidative stress, and reversed the prediabetic condition in 24% of the evaluated patients.

Keywords: flavonoids; hyperglycemia; insulin resistance; prediabetic state.

Conflict of interest statement

The sponsors had no role in the design, execution, interpretation, or writing of the study.

© 2019 The Authors Phytotherapy Research Published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Trial design
Figure 2
Figure 2
Percentage of individuals with prediabetic after Eriomin supplementation

References

    1. American Diabetes Association (2018). Classification and diagnosis of diabetes: Standards of medical care in diabetes. Diabetes Care, 41, S13–S27. 10.2337/dc18-S002
    1. Banerjee, A. , Khemka, V. K. , Roy, D. , Poddar, J. , Roy, T. K. S. , & Karnam, S. A. (2017). Role of serum adiponectin and vitamin D in prediabetes and diabetes mellitus. Canadian Journal of Diabetes, 41, 259–265. 10.1016/j.jcjd.2016.10.006
    1. Brannick, B. , Wynn, A. , & Dagogo‐Jack, S. (2016). Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Experimental Biology and Medicine, 241(12), 1323–1331. 10.1177/1535370216654227
    1. Bucolo, C. , Leggio, G. M. , Drago, F. , & Salomone, S. (2012). Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin‐induced diabetic rats. Biochemical Pharmacology, 84(1), 88–92. 10.1016/j.bcp.2012.03.019
    1. Demonty, I. , Lin, Y. , Zebregs, Y. E. , Vermeer, M. A. , van der Knaap, H. C. , Jäkel, M. , & Trautwein, E. A. (2010). The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. The Journal of Nutrition, 140(9), 1615–1620. 10.3945/jn.110.124735
    1. Domínguez Avila, J. A. , Rodrigo García, J. , González Aguilar, G. A. , & Rosa, L. A. (2017). The antidiabetic mechanisms of polyphenols related to increased glucagon‐like peptide‐1 (GLP1) and insulin signaling. Molecules, 22(6), E903–E919. 10.3390/molecules22060903
    1. Dorcely, B. , Katz, K. , Jagannathan, R. , Chiang, S. S. , Oluwadare, B. , Goldberg, I. J. , & Bergman, M. (2017). Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 10, 345–361. 10.2147/DMSO.S100074
    1. Ferreira, P. S. , Spolidorio, L. C. , Manthey, J. A. , & Cesar, T. B. (2016). Citrus flavanones prevent systemic inflammation and ameliorate oxidative stress in C57BL/6J mice fed high‐fat diet. Food & Function, 7(6), 2675–2681. 10.1039/c5fo01541c
    1. Forbes, J. M. , & Cooper, M. E. (2013). Mechanisms of diabetic complications. Physiological Reviews, 93(1), 137–188. 10.1152/physrev.00045.2011
    1. Friedwald, W. T. , Levy, R. I. , & Friedrickson, D. S. (1972). Estimation of concentration of LDL cholesterol in plasma without preparation or ultracentrifugation. Clinical Chemistry, 18, 499–502. PMID: 4337382
    1. Fukuchi, Y. , Hiramitsu, M. , Okada, M. , Hayashi, S. , Nabeno, Y. , Osawa, T. , & Naito, M. (2008). Lemon polyphenols suppress diet‐induced obesity by up regulation of mRNA levels of the enzymes involved in β‐oxidation in mouse white adipose tissue. Journal of Clinical Biochemistry and Nutrition, 43(3), 201–209. 10.3164/jcbn.2008066
    1. Gamo, K. , Miyachi, H. , Nakamura, K. , & Matsuura, N. (2014). Hesperetin glucuronides induce adipocyte differentiation via activation and expression of peroxisome proliferator‐activated receptor‐γ. Bioscience, Biotechnology, and Biochemistry, 78(6), 1052–1059. 10.1080/09168451.2014.910097
    1. Gastaldelli, A. , Gaggini, M. , & DeFronzo, R. (2017). Glucose kinetics: An update and novel insights into its regulation by glucagon and GLP‐1. Current Opinion in Clinical Nutrition and Metabolic Care, 20(4), 300–309. 10.1097/MCO.0000000000000384
    1. Haidari, F. , Heybar, H. , Jalali, M. T. , Ahmadi Engali, K. , Helli, B. , & Shirbeigi, E. (2015). Hesperidin supplementation modulates inflammatory responses following myocardial infarction. Journal of the American College of Nutrition, 34(3), 205–211. 10.1080/07315724.2014.891269
    1. Hiramitsu, M. , Shimada, Y. , Kuroyanagi, J. , Inoue, T. , Katagiri, T. , Zang, L. , … Tanaka, T. (2014). Eriocitrin ameliorates diet‐induced hepatic steatosis with activation of mitochondrial biogenesis. Scientific Reports, 4, 3708–3719. 10.1038/srep03708
    1. Homayouni, F. , Haidari, F. , Hedayati, M. , Zakerkish, M. , & Ahmadi, K. (2018). Blood pressure lowering and anti‐inflammatory effects of hesperidin in type 2 diabetes; a randomized double‐blind controlled clinical trial. Phytotherapy Research, 32(6), 1073–1079. 10.1002/ptr.6046
    1. International Diabetes Federation (2017). IDF Diabetes Atlas (8th ed.). Brussels, Belgium: International Diabetes Federation; Retrieved from
    1. Jayaraman, R. , Subramani, S. , Sheik Abdullah, S. H. , & Udaiyar, M. (2018). Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin‐induced diabetic rats. Biomedicine & Pharmacotherapy, 97, 98–106. 10.1016/j.biopha.2017.10.102
    1. Jung, U. J. , Lee, M. K. , Jeong, K. S. , & Choi, M. S. (2004). The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose‐regulating enzymes in C57BL/KsJ‐db/db mice. The Journal of Nutrition, 134(10), 2499–2503. PMID: 15465737. 10.1093/jn/134.10.2499
    1. Jung, U. J. , Lee, M. K. , Park, Y. B. , Kang, M. A. , & Choi, M. S. (2006). Effect of citrus flavonoids on lipid metabolism and glucose‐regulating enzyme mRNA levels in type‐2 diabetic mice. The International Journal of Biochemistry & Cell Biology, 38(7), 1134–1145. PMID:16427799. 10.1016/j.biocel.2005.12.002
    1. Kawser Hossain, M. , Abdal Dayem, A. , Han, J. , Yin, Y. , Kim, K. , Kumar Saha, S. , … Cho, S. G. (2016). Molecular mechanisms of the anti‐obesity and anti‐diabetic properties of flavonoids. International Journal of Molecular Sciences, 17(4), 569–601. 10.3390/ijms17040569
    1. Kim, J. D. , Kang, S. J. , Lee, M. K. , Park, S. E. , Rhee, E. J. , Park, C. Y. , … Lee, W. Y. (2016). C‐peptide‐based index is more related to incident type 2 diabetes in non‐diabetic subjects than insulin‐based index. Endocrinology and Metabolism, 31, 320–327. 10.3803/EnM.2016.31.2.320
    1. Lai, H. , Lin, N. , Xing, Z. , Weng, H. , & Zhang, H. (2015). Association between the level of circulating adiponectin and prediabetes: A meta‐analysis. Journal of Diabetes Investigation, 6(4), 416–429. 10.1111/jdi.12321
    1. Lee, J. K. (2011). Anti‐inflammatory effects of eriodictyol in lipopolysaccharide‐stimulated raw 264.7 murine macrophages. Archives of Pharmacal Research, 34(4), 671–679. 10.1007/s12272-011-0418-3
    1. Li, C. Z. , Jin, H. H. , Sun, H. X. , Zhang, Z. Z. , Zheng, J. X. , Li, S. H. , & Han, S. H. (2016). Eriodictyol attenuates cisplatin‐induced kidney injury by inhibiting oxidative stress and inflammation. European Journal of Pharmacology, 772, 124–130. 10.1016/j.ejphar.2015.12.042
    1. Liu, L. , Shan, S. , Zhang, K. , Ning, Z. Q. , Lu, X. P. , & Cheng, Y. Y. (2008). Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up‐regulate transcription of adiponectin. Phytotherapy Research, 22(10), 1400–1403. 10.1002/ptr.2504
    1. Matthews, D. , Hosker, J. P. , Rudenski, A. S. , Naylor, B. A. , Treacher, D. F. , & Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and β‐cell function from man. Diabetologia, 28, 412–419. PMID: 3899825. 10.1007/BF00280883
    1. Minato, K. , Miyake, Y. , Fukumoto, S. , Yamamoto, K. , Kato, Y. , Shimomura, Y. , & Osawa, T. (2003). Lemon flavonoid, eriocitrin, suppresses exercise‐induced oxidative damage in rat liver. Life Sciences, 72(14), 1609–1616. PMID: 12551749. 10.1016/S0024-3205(02)02443-8
    1. Miyake, Y. , Suzuki, E. , Ohya, S. , Fukumoto, S. , Hiramitsu, M. , Sakaida, K. , … Furuichi, Y. (2006). Lipid‐lowering effect of eriocitrin, the main flavonoid in lemon fruit, in rats on a high‐fat and high‐cholesterol diet. Journal of Food Science, 71, S633–S637. 10.1111/j.1750-3841.2006.00192.x
    1. Miyake, Y. , Yamamoto, K. , Tsujihara, N. , & Osawa, T. (1998). Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids, 33(7), 689–695. PMID: 9688172. 10.1007/s11745-998-0258-y
    1. Mohammadi, M. , Eghtesadi, S. , Vafa, M. , Haghighian, H. K. , Heydari, I. , Salehi, M. , … Alipour, R. (2015). Effects of hesperidin supplementation on glycemic control, lipid profile and inflammatory markers in patients with type 2 diabetes: A randomized double blind placebo control clinical trial. Research Article, Acta Biologica Indica, 4, 75–83. eISSN 2279–0160
    1. Morand, C. , Dubray, C. , Milenkovic, D. , Lioger, D. , Martin, J. F. , Scalbert, A. , & Mazur, A. (2011). Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. The American Journal of Clinical Nutrition, 93(1), 73–80. 10.3945/ajcn.110.004945
    1. Navarro, J. F. , & Mora, C. (2006). Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Scientific World Journal, 6, 908–917. PMID: 16906324. 10.1100/tsw.2006.179
    1. Ozer, J. , Ratner, M. , Shaw, M. , Bailey, W. , & Schomaker, S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology, 245(3), 194–205. 10.1016/j.tox.2007.11.021
    1. Parhiz, H. , Roohbakhsh, A. , Soltani, F. , Rezaee, R. , & Iranshahi, M. (2015). Antioxidant and anti‐inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytotherapy Research, 29(3), 323–331. 10.1002/ptr.5256
    1. Parmar, H. S. , Jain, P. , Chauhan, D. S. , Bhinchar, M. K. , Munjal, V. , Yusuf, M. , … Kumar, A. (2012). DPP‐IV inhibitory potential of naringin: An in silico, in vitro and in vivo study. Diabetes Research and Clinical Practice, 97(1), 105–111. 10.1016/j.diabres.2012.02.011
    1. Re, R. , Pellegrini, N. , Proteggente, A. , Pannala, A. , Yang, M. , & Rice‐Evans, C. (1999). Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biology & Medicine, 26, 1231–1237. 10.1016/S0891-5849(98)00315-3
    1. Rehman, K. , & Akash, M. S. H. (2017). Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: How are they interlinked? Journal of Cellular Biochemistry, 118(11), 3577–3585. 10.1002/jcb.26097
    1. Roberts, S. , Craig, D. , Adler, A. , McPherson, K. , & Greenhalgh, T. (2018). Economic evaluation of type 2 diabetes prevention programmes: Markov model of low‐ and high‐intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia. BMC Medicine, 16(1), 16–28. 10.1186/s12916-017-0984-4
    1. Sireesh, D. , Dhamodharan, U. , Ezhilarasi, K. , Vijay, V. , & Ramkumar, K. M. (2018). Association of NF‐E2 related factor 2 (Nrf2) and inflammatory cytokines in recent onset type 2 diabetes mellitus. Scientific Reports, 8, 5126–5136. 10.1038/s41598-018-22913-6
    1. Sociedade Brasileira de Nefrologia (2011). e‐book. Biomarcadores na Nefrologia. Editor. HugoAbensur. Professor Livre‐Docent e de Nefrologiada Faculdade deMedicina da Universidade de Sao Paulo.
    1. Unicamp (2006). Tabela Brasileira de Composição de Alimentos. TACO. 2aed. Campinas; Nucleo de Estudos e Pesquisas emAlimentacao – NEPA, Universidade Estadual de Campinas – UNICAMP;
    1. Wang, X. L. , Ye, F. , Li, J. , Zhu, L. Y. , Feng, G. , Chang, X. Y. , & Sun, K. (2016). Impaired secretion of glucagon‐like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus. Saudi Medical Journal, 37(1), 48–54. 10.15537/smj.2016.1.12035.
    1. Wasserman, D. H. , Wang, T. J. , & Brown, N. J. (2018). The vasculature in prediabetes. Circulation Research, 122(8), 1135–1150. 10.1161/circresaha.118.311912
    1. WHO Expert Consultation . (2008). Waist circumference and waist‐to‐hip ratio: Report of WHO Expert Consultation, Geneva.
    1. Yagi, K. (1998). Simple assay for the level of total lipid peroxides in serum or plasma. Methods in Molecular Biology, 108, 101–106. 10.1385/0-89603-472-0:101
    1. Yi, L. , Ma, S. , & Ren, D. (2017). Phytochemistry and bioactivity of citrus flavonoids: A focus on antioxidant, anti‐inflammatory, anticancer and cardiovascular protection activities. Phytochemistry Reviews, 16(3), 479–511. 10.1007/s11101-017-9497-1
    1. Yoshida, H. , Watanabe, W. , Oomagari, H. , Tsuruta, E. , Shida, M. , & Kurokawa, M. (2013). Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes. The Journal of Nutritional Biochemistry, 24, 1276–1284. 10.1016/j.jnutbio.2012.10.003
    1. Zaidun, N. H. , Thent, Z. C. , & Latiff, A. A. (2018). Combating oxidative stress disorders with citrus flavonoid: Naringenin. Life Sciences, 208, 111–122. 10.1016/j.lfs.2018.07.017
    1. Zhang, W. Y. , Lee, J. J. , Kim, Y. , Kim, I. S. , Han, J. H. , Lee, S. G. , … Myung, C. S. (2012). Effect of eriodictyol on glucose uptake and insulin resistance in vitro. Journal of Agricultural and Food Chemistry, 60(31), 7652–7658. 10.1021/jf300601z

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe